Honeywell International has reaffirmed its full-year 2026 financial guidance, projecting sales between $38.8 billion and $39.8 billion and adjusted EPS of $10.35 to $10.65, ahead of its aerospace business spin-off. The company also provided preliminary guidance for Honeywell Technologies, its remaining automation and process businesses, anticipating sales between $19.9 billion and $20.2 billion post-spin-off. The aerospace spin-off is set to complete on June 29, 2026, with the new entity trading under the ticker "HONA" on Nasdaq.

Johnson & Johnson has agreed to acquire Firefly Bio for $1 billion in cash, bolstering its cancer drug pipeline with Firefly's degrader-antibody conjugate (DAC) platform aimed at pan-KRAS targets. This acquisition enhances J&J's efforts in KRAS-targeting therapies, a field previously considered undruggable, and complements its existing partnership with Jacobio Pharma for a KRAS G12C inhibitor. The deal focuses on developing treatments for various solid tumors driven by KRAS mutations, which are common in many cancers.

Mizuho Securities has increased its price target for DexCom (DXCM) to $85 from $75, while reiterating an "Outperform" rating on the stock. This adjustment follows recent news including Dexcom's G7 continuous glucose monitor showing positive results for non-insulin dependent Type 2 diabetic patients. The article also lists other recent analyst adjustments and company news for DexCom.

Enphase Energy saw a significant 5.8% increase in its stock price, reaching $59.33, as part of a broader sector-wide rally that also benefited several other solar technology companies. This surge, driven by collective market momentum rather than company-specific news, suggests shifting investor sentiment and potential institutional participation in renewable energy infrastructure. Investors are advised to monitor the sector's sustained performance and any future company-specific catalysts for Enphase.

J.M. Smucker Company is set to release its fiscal fourth-quarter earnings, with investors keenly watching the performance of its core brands against the backdrop of persistent struggles with its Hostess business. Analysts anticipate earnings of $2.65 per share on revenue of $2.26 billion, driven by the strength of brands like Uncrustables, Jif, and Folgers coffee. The article also notes that Smucker will face scrutiny regarding its strategy for the troubled Hostess brand, which has incurred significant impairment charges and seen analysts suggest a potential disposal.

A new report from Bloomberg details internal shifts at Apple that led to major AI upgrades in iOS 27, including an overhaul of Siri. The changes came after Apple Intelligence initially flopped in 2024, leading to a critical meeting of executives and a new partnership with Google for Gemini technology. This strategic pivot resulted in Craig Federighi overseeing Siri development with Mike Rockwell leading the effort.

KeyBanc has reiterated an "Overweight" rating and an $83.00 price target for CMS Energy following a CFO transition, viewing the recent stock pullback as an overdone reaction. The firm believes the weakness presents a compelling investment opportunity, citing durable growth and strong execution. Despite some analyst caution and a recent downgrade from Jefferies, KeyBanc is confident in the orderly transition and continuity of the management team.

Kimberly-Clark (KMB) has a market cap of $32.9 billion and is known for brands like Huggies and Kleenex. Despite its strong brand portfolio and R&D efforts, the stock has underperformed the consumer staples sector, represented by the State Street Consumer Staples Select Sector SPDR ETF (XLP), over the past three months and year-to-date. Wall Street analysts maintain a "Moderate Buy" rating for KMB, with a potential upside of 14.6%.

Argosy Investors highlighted Fomento Económico Mexicano, S.A.B. de C.V. (FMX) in its Q1 2026 investor letter, indicating a shift from Coca-Cola FEMSA (KOF) to FMX for its exposure to Coca-Cola and its convenience store growth. Despite FMX's strong past performance, Argosy Investors remains cautious due to skepticism about the durability of earnings in the transformative investment landscape driven by the AI capex boom. The firm suggests that some AI stocks may offer more promising returns in a shorter timeframe, though FMX is not currently among the 40 most popular stocks among hedge funds.

KLA Corp (KLAC) has been analyzed using DCF models, revealing that the company is significantly overvalued with an intrinsic value of $1701.68 based on earnings and $947.25 based on free cash flow, compared to its current price of $1929.20. The GF Value™ also indicates overvaluation at $995.76, while its GF Score™ of 87/100 and a predictability rank of 4/5 suggest reliability in the DCF analysis. Investors are advised that KLA Corp is overvalued based on a consensus of these valuation models.